Lesion distribution and substrate of white matter damage in myotonic dystrophy type 1: Comparison with multiple sclerosis.


Journal

NeuroImage. Clinical
ISSN: 2213-1582
Titre abrégé: Neuroimage Clin
Pays: Netherlands
ID NLM: 101597070

Informations de publication

Date de publication:
2021
Historique:
received: 07 09 2020
revised: 06 01 2021
accepted: 08 01 2021
pubmed: 1 2 2021
medline: 29 6 2021
entrez: 31 1 2021
Statut: ppublish

Résumé

Myotonic Dystrophy type 1 (DM1) is an autosomal dominant condition caused by expansion of the CTG triplet repeats within the myotonic dystrophy protein of the kinase (DMPK) gene. The central nervous system is involved in the disease, with multiple symptoms including cognitive impairment. A typical feature of DM1 is the presence of widespread white matter (WM) lesions, whose total volume is associated with CTG triplet expansion. The aim of this study was to characterize the distribution and pathological substrate of these lesions as well as the normal appearing WM (NAWM) using quantitative magnetization transfer (qMT) MRI, and comparing data from DM1 patients with those from patients with multiple sclerosis (MS). Twenty-eight patients with DM1, 29 patients with relapsing-remitting MS, and 15 healthy controls had an MRI scan, including conventional and qMT imaging. The average pool size ratio (F), a proxy of myelination, was computed within lesions and NAWM for every participant. The lesion masks were warped into MNI space and lesion probability maps were obtained for each patient group. The lesion distribution, total lesion load and the tissue-specific mean F were compared between groups. The supratentorial distribution of lesions was similar in the 2 patient groups, although mean lesion volume was higher in MS than DM1. DM1 presented higher prevalence of anterior temporal lobe lesions, but none in the cerebellum and brainstem. Significantly reduced F values were found within DM1 lesions, suggesting a loss of myelin density. While F was reduced in the NAWM of MS patients, it did not differ between DM1 and controls. Our results provide further evidence for a need to compare histology and imaging using new MRI techniques in DM1 patients, in order to further our understanding of the underlying disease process contributing to WM disease.

Identifiants

pubmed: 33516936
pii: S2213-1582(21)00006-1
doi: 10.1016/j.nicl.2021.102562
pmc: PMC7848627
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

102562

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Sara Leddy (S)

Clinical Imaging Sciences Centre, Brighton and Sussex Medical School, Brighton, United Kingdom; Brighton and Sussex University Hospital Trust, Brighton, United Kingdom.

Laura Serra (L)

Neuroimaging Laboratory, Santa Lucia Foundation, Rome, Italy.

Davide Esposito (D)

Clinical Imaging Sciences Centre, Brighton and Sussex Medical School, Brighton, United Kingdom.

Camilla Vizzotto (C)

Clinical Imaging Sciences Centre, Brighton and Sussex Medical School, Brighton, United Kingdom.

Giovanni Giulietti (G)

Neuroimaging Laboratory, Santa Lucia Foundation, Rome, Italy.

Gabriella Silvestri (G)

Department of Neuroscience, Fondazione Policlinico Gemelli IRCCS, Università Cattolica del S. Cuore, Rome, Italy.

Antonio Petrucci (A)

UOC Neurologia e Neurofisiopatologia, AO San Camillo Forlanini, Rome, Italy.

Giovanni Meola (G)

Department of Neurorehabilitation Sciences, Casa di Cura Policlinico, Milan, Italy; Department of Biomedical Science for Health, University of Milan, Milan, Italy.

Leonardo Lopiano (L)

'Rita Levi Montalcini' Department of Neuroscience, University of Torino, Turin, Italy.

Mara Cercignani (M)

Clinical Imaging Sciences Centre, Brighton and Sussex Medical School, Brighton, United Kingdom; Neuroimaging Laboratory, Santa Lucia Foundation, Rome, Italy.

Marco Bozzali (M)

Clinical Imaging Sciences Centre, Brighton and Sussex Medical School, Brighton, United Kingdom; UOC Neurologia e Neurofisiopatologia, AO San Camillo Forlanini, Rome, Italy. Electronic address: marco.bozzali@unito.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH